Skip to main content
logo
Rhythm Pharmaceuticals, Inc. (RYTM)
NASDAQ: RYTM · Real-Time Price · USD
107.28
-6.06 (-5.35%)
Jan 15, 2026, 3:03 PM EST - Market open

Revenue by Product

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21
Therapeutics
130.13M
Log In
Log In
Log In
Therapeutics Growth
68.06%
Log In
Log In
Log In

Revenue by Geography

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21
United States
96.11M
Log In
Log In
Log In
United States Growth
53.96%
Log In
Log In
Log In
International
34.02M
Log In
Log In
Log In
Germany
-
Log In
Log In
Log In
Other
-
Log In
Log In
Log In